As of 2026-02-07, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 54.06 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.13 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is -7.0%.
The range of the Relative Valuation is 44.86 - 65.44 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 19.6x | 17.8x |
| Forward P/E multiples | 18.4x - 22.1x | 20.2x |
| Fair Price | 44.86 - 65.44 | 54.06 |
| Upside | -22.8% - 12.6% | -7.0% |
| Date | P/E |
| 2026-02-06 | 21.46 |
| 2026-02-05 | 21.10 |
| 2026-02-04 | 21.27 |
| 2026-02-03 | 21.27 |
| 2026-02-02 | 21.39 |
| 2026-01-30 | 20.87 |
| 2026-01-29 | 21.04 |
| 2026-01-28 | 20.92 |
| 2026-01-27 | 20.99 |
| 2026-01-26 | 20.96 |
| 2026-01-23 | 20.75 |
| 2026-01-22 | 21.11 |
| 2026-01-21 | 20.96 |
| 2026-01-20 | 20.79 |
| 2026-01-16 | 20.15 |
| 2026-01-15 | 20.33 |
| 2026-01-14 | 20.70 |
| 2026-01-13 | 20.38 |
| 2026-01-12 | 21.30 |
| 2026-01-09 | 21.76 |
| 2026-01-08 | 22.28 |
| 2026-01-07 | 22.63 |
| 2026-01-06 | 22.17 |
| 2026-01-05 | 21.73 |
| 2026-01-02 | 21.95 |
| 2025-12-31 | 21.94 |
| 2025-12-30 | 21.78 |
| 2025-12-29 | 22.16 |
| 2025-12-26 | 22.13 |
| 2025-12-24 | 22.21 |
| 2025-12-23 | 22.57 |
| 2025-12-22 | 21.88 |
| 2025-12-19 | 22.57 |
| 2025-12-18 | 19.18 |
| 2025-12-17 | 19.12 |
| 2025-12-16 | 19.11 |
| 2025-12-15 | 19.24 |
| 2025-12-12 | 19.68 |
| 2025-12-11 | 19.56 |
| 2025-12-10 | 19.82 |
| 2025-12-09 | 19.84 |
| 2025-12-08 | 19.68 |
| 2025-12-05 | 19.71 |
| 2025-12-04 | 19.87 |
| 2025-12-03 | 20.05 |
| 2025-12-02 | 19.89 |
| 2025-12-01 | 20.31 |
| 2025-11-28 | 20.65 |
| 2025-11-26 | 20.50 |
| 2025-11-25 | 20.78 |